Capitalization 2.42B 202B P/E ratio 2024 *
-16.2x
P/E ratio 2025 * -86.1x
Enterprise value 3.02B 252B EV / Sales 2024 *
3.69x
EV / Sales 2025 * 3.45x
Free-Float
76.56%
Yield 2024 *
-
Yield 2025 * -
More valuation ratios * Estimated data
Dynamic Chart
1 day+0.34%
1 week+5.50%
Current month-0.04%
1 month-1.88%
3 months-11.65%
6 months-15.67%
Current year-24.01%
More quotes
1 week
47.56
Extreme 47.555
51.26
1 month
45.21
Extreme 45.21
51.26
Current year
45.21
Extreme 45.21
69.16
1 year
44.00
Extreme 44
69.16
3 years
36.01
Extreme 36.01
124.79
5 years
21.19
Extreme 21.19
124.79
10 years
8.33
Extreme 8.33
124.79
More quotes
Director TitleAgeSince
Chief Executive Officer 44 09/09
Director of Finance/CFO 50 16/23/16
Chief Operating Officer - 01/14/01
Manager TitleAgeSince
Director/Board Member 63 28/13/28
Director/Board Member 76 05/18/05
Director/Board Member 48 03/20/03
More insiders
Add to a list
Change 5d. change 1-year change 3-years change Capi. ($)
+0.34%+5.50%+0.32%-47.42%2.42B
-1.85%-4.33%+20.44%-29.08%46.11B
+0.80%+2.61%+17.11%-4.57%44.59B
+1.16%+5.58%+57.31%+45.18%35.48B
+3.23%+3.02%+38.39%-22.41%31.29B
-2.63%-2.38%-36.28%-84.18%26.15B
-0.51%+0.41%+14.31%+12.20%24.92B
+2.55%+3.00%+59.21%+75.59%15.63B
+5.03%+9.78%+13.78%-39.84%12.75B
+2.18%+7.03%+44.36%+98.46%11.42B
Average +1.16%+3.42%+22.90%+0.39% 25.08B
Weighted average by Cap. +0.75%+2.41%+23.75%-3.42%
See all sector performances
2024 *2025 *
Net sales 656M 54.74B 703M 58.67B
Net income -163M -13.61B -23.37M -1.95B
Net Debt - -
More financial data * Estimated data
Logo Azenta, Inc.
Azenta, Inc. is a provider of biological and chemical compound sample exploration and management solutions for the life sciences industry. The Company’s segments include Sample Management Solutions, Multiomics and B Medical Systems. The Sample Management Solutions segment offers end-to-end sample management products and services, including sample and repository services and core products (automated stores, cryogenic systems, automated sample tube, and consumables and instruments). The Multiomics segment provides genomic and other sample analysis services, including gene sequencing and gene synthesis. B Medical Systems segment is focused on the manufacturing and distribution of temperature-controlled storage and transportation solutions in international markets to governments, health institutions, and non-government organizations. It provides products and services through its brands, including GENEWIZ, FluidX, Ziath, 4titude, Limfinity, Freezer Pro, Barkey, and B Medical Systems.
Employees
3,300
More about the company
Date Price Change Volume
19/24/19 49.50 $ +0.34% 711,897
18/24/18 49.33 $ +0.51% 664,109
17/24/17 49.08 $ +2.16% 599,690
16/24/16 48.04 $ -0.99% 885,785
13/24/13 48.52 $ +3.41% 717,200

Delayed Quote Nasdaq, September 20, 2024 at 01:30 am IST

More quotes
Trading Rating
Investor Rating
ESG Refinitiv
B+
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
7
Last Close Price
49.50USD
Average target price
62.40USD
Spread / Average Target
+26.06%
Consensus